Voriconazole - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 25-Dec-2023
No. of pages: 110
Inquire Before Buying

The global Voriconazole market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Voriconazole in various end use industries. The expanding demands from the Hospital, Clinic and Other,, are propelling Voriconazole market. Injection Voriconazole, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Voriconazole Freeze-dried Powder segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Voriconazole market, driven by demand from China, the second largest economy with some signs of stabilising, the Voriconazole market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Voriconazole, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Voriconazole market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Voriconazole market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Voriconazole sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Voriconazole covered in this report include Pfizer, Teva, GeneTech Pharm, Novartis, Mylan, Squibb, Sandoz, Daiichi Sankyo and GSK, etc.

The global Voriconazole market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- Pfizer

- Teva

- GeneTech Pharm

- Novartis

- Mylan

- Squibb

- Sandoz

- Daiichi Sankyo

- GSK

- Cilag AG

- Macherey-Nagel GmbH

- Abbott

- Takeda

- Sichuan Beauty Sport Huakang Pharmaceutical

- Jincheng HEALTH Pharmaceutical

- Ebang Pharmaceutical

- Aditya Pharma

- Taj Pharmaceuticals

Global Voriconazole market, By Region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Voriconazole market, Segment by Type:

- Injection Voriconazole

- Voriconazole Freeze-dried Powder

Global Voriconazole market, by Application

- Hospital

- Clinic

- Other

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Two: Detailed analysis of Voriconazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Voriconazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Voriconazole - Global Market Insights and Sales Trends 2024

Table of Contents
1 Voriconazole Market Overview
1.1 Voriconazole Product Overview
1.2 Voriconazole Market Segment by Type
1.2.1 Injection Voriconazole
1.2.2 Voriconazole Freeze-dried Powder
1.3 Global Voriconazole Market Size by Type
1.3.1 Global Voriconazole Market Size Overview by Type (2018-2029)
1.3.2 Global Voriconazole Historic Market Size Review by Type (2018-2023)
1.3.3 Global Voriconazole Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Voriconazole Sales Breakdown by Type (2018-2023)
1.4.2 Europe Voriconazole Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Voriconazole Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Voriconazole Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Voriconazole Sales Breakdown by Type (2018-2023)
2 Global Voriconazole Market Competition by Company
2.1 Global Top Players by Voriconazole Sales (2018-2023)
2.2 Global Top Players by Voriconazole Revenue (2018-2023)
2.3 Global Top Players by Voriconazole Price (2018-2023)
2.4 Global Top Manufacturers Voriconazole Manufacturing Base Distribution, Sales Area, Product Type
2.5 Voriconazole Market Competitive Situation and Trends
2.5.1 Voriconazole Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Voriconazole Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Voriconazole as of 2022)
2.7 Date of Key Manufacturers Enter into Voriconazole Market
2.8 Key Manufacturers Voriconazole Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Voriconazole Status and Outlook by Region
3.1 Global Voriconazole Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Voriconazole Historic Market Size by Region
3.2.1 Global Voriconazole Sales in Volume by Region (2018-2023)
3.2.2 Global Voriconazole Sales in Value by Region (2018-2023)
3.2.3 Global Voriconazole Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Voriconazole Forecasted Market Size by Region
3.3.1 Global Voriconazole Sales in Volume by Region (2024-2029)
3.3.2 Global Voriconazole Sales in Value by Region (2024-2029)
3.3.3 Global Voriconazole Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Voriconazole by Application
4.1 Voriconazole Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Voriconazole Market Size by Application
4.2.1 Global Voriconazole Market Size Overview by Application (2018-2029)
4.2.2 Global Voriconazole Historic Market Size Review by Application (2018-2023)
4.2.3 Global Voriconazole Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Voriconazole Sales Breakdown by Application (2018-2023)
4.3.2 Europe Voriconazole Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Voriconazole Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Voriconazole Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Voriconazole Sales Breakdown by Application (2018-2023)
5 North America Voriconazole by Country
5.1 North America Voriconazole Historic Market Size by Country
5.1.1 North America Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Voriconazole Sales in Volume by Country (2018-2023)
5.1.3 North America Voriconazole Sales in Value by Country (2018-2023)
5.2 North America Voriconazole Forecasted Market Size by Country
5.2.1 North America Voriconazole Sales in Volume by Country (2024-2029)
5.2.2 North America Voriconazole Sales in Value by Country (2024-2029)
6 Europe Voriconazole by Country
6.1 Europe Voriconazole Historic Market Size by Country
6.1.1 Europe Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Voriconazole Sales in Volume by Country (2018-2023)
6.1.3 Europe Voriconazole Sales in Value by Country (2018-2023)
6.2 Europe Voriconazole Forecasted Market Size by Country
6.2.1 Europe Voriconazole Sales in Volume by Country (2024-2029)
6.2.2 Europe Voriconazole Sales in Value by Country (2024-2029)
7 Asia-Pacific Voriconazole by Region
7.1 Asia-Pacific Voriconazole Historic Market Size by Region
7.1.1 Asia-Pacific Voriconazole Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Voriconazole Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Voriconazole Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Voriconazole Forecasted Market Size by Region
7.2.1 Asia-Pacific Voriconazole Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Voriconazole Sales in Value by Region (2024-2029)
8 Latin America Voriconazole by Country
8.1 Latin America Voriconazole Historic Market Size by Country
8.1.1 Latin America Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Voriconazole Sales in Volume by Country (2018-2023)
8.1.3 Latin America Voriconazole Sales in Value by Country (2018-2023)
8.2 Latin America Voriconazole Forecasted Market Size by Country
8.2.1 Latin America Voriconazole Sales in Volume by Country (2024-2029)
8.2.2 Latin America Voriconazole Sales in Value by Country (2024-2029)
9 Middle East and Africa Voriconazole by Country
9.1 Middle East and Africa Voriconazole Historic Market Size by Country
9.1.1 Middle East and Africa Voriconazole Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Voriconazole Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Voriconazole Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Voriconazole Forecasted Market Size by Country
9.2.1 Middle East and Africa Voriconazole Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Voriconazole Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Voriconazole Products Offered
10.1.5 Pfizer Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Voriconazole Products Offered
10.2.5 Teva Recent Development
10.3 GeneTech Pharm
10.3.1 GeneTech Pharm Company Information
10.3.2 GeneTech Pharm Introduction and Business Overview
10.3.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GeneTech Pharm Voriconazole Products Offered
10.3.5 GeneTech Pharm Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Voriconazole Products Offered
10.4.5 Novartis Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Voriconazole Products Offered
10.5.5 Mylan Recent Development
10.6 Squibb
10.6.1 Squibb Company Information
10.6.2 Squibb Introduction and Business Overview
10.6.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Squibb Voriconazole Products Offered
10.6.5 Squibb Recent Development
10.7 Sandoz
10.7.1 Sandoz Company Information
10.7.2 Sandoz Introduction and Business Overview
10.7.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sandoz Voriconazole Products Offered
10.7.5 Sandoz Recent Development
10.8 Daiichi Sankyo
10.8.1 Daiichi Sankyo Company Information
10.8.2 Daiichi Sankyo Introduction and Business Overview
10.8.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Daiichi Sankyo Voriconazole Products Offered
10.8.5 Daiichi Sankyo Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Introduction and Business Overview
10.9.3 GSK Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GSK Voriconazole Products Offered
10.9.5 GSK Recent Development
10.10 Cilag AG
10.10.1 Cilag AG Company Information
10.10.2 Cilag AG Introduction and Business Overview
10.10.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cilag AG Voriconazole Products Offered
10.10.5 Cilag AG Recent Development
10.11 Macherey-Nagel GmbH
10.11.1 Macherey-Nagel GmbH Company Information
10.11.2 Macherey-Nagel GmbH Introduction and Business Overview
10.11.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Macherey-Nagel GmbH Voriconazole Products Offered
10.11.5 Macherey-Nagel GmbH Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Voriconazole Products Offered
10.12.5 Abbott Recent Development
10.13 Takeda
10.13.1 Takeda Company Information
10.13.2 Takeda Introduction and Business Overview
10.13.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Takeda Voriconazole Products Offered
10.13.5 Takeda Recent Development
10.14 Sichuan Beauty Sport Huakang Pharmaceutical
10.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
10.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Introduction and Business Overview
10.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Products Offered
10.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
10.15 Jincheng HEALTH Pharmaceutical
10.15.1 Jincheng HEALTH Pharmaceutical Company Information
10.15.2 Jincheng HEALTH Pharmaceutical Introduction and Business Overview
10.15.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Jincheng HEALTH Pharmaceutical Voriconazole Products Offered
10.15.5 Jincheng HEALTH Pharmaceutical Recent Development
10.16 Ebang Pharmaceutical
10.16.1 Ebang Pharmaceutical Company Information
10.16.2 Ebang Pharmaceutical Introduction and Business Overview
10.16.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Ebang Pharmaceutical Voriconazole Products Offered
10.16.5 Ebang Pharmaceutical Recent Development
10.17 Aditya Pharma
10.17.1 Aditya Pharma Company Information
10.17.2 Aditya Pharma Introduction and Business Overview
10.17.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Aditya Pharma Voriconazole Products Offered
10.17.5 Aditya Pharma Recent Development
10.18 Taj Pharmaceuticals
10.18.1 Taj Pharmaceuticals Company Information
10.18.2 Taj Pharmaceuticals Introduction and Business Overview
10.18.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Taj Pharmaceuticals Voriconazole Products Offered
10.18.5 Taj Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Voriconazole Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Voriconazole Industrial Chain Analysis
11.4 Voriconazole Market Dynamics
11.4.1 Voriconazole Industry Trends
11.4.2 Voriconazole Market Drivers
11.4.3 Voriconazole Market Challenges
11.4.4 Voriconazole Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Voriconazole Distributors
12.3 Voriconazole Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Injection Voriconazole
Table 2. Major Company of Voriconazole Freeze-dried Powder
Table 3. Global Voriconazole Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Voriconazole Sales by Type (2018-2023) & (K Pcs)
Table 5. Global Voriconazole Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Voriconazole Sales by Type (2018-2023) & (US& Million)
Table 7. Global Voriconazole Market Share in Value by Type (2018-2023)
Table 8. Global Voriconazole Price by Type (2018-2023) & (USD/Pcs)
Table 9. Global Voriconazole Sales by Type (2024-2029) & (K Pcs)
Table 10. Global Voriconazole Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Voriconazole Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Voriconazole Sales Market Share in Value by Type (2024-2029)
Table 13. Global Voriconazole Price by Type (2024-2029) & (USD/Pcs)
Table 14. North America Voriconazole Sales by Type (2018-2023) & (K Pcs)
Table 15. North America Voriconazole Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Voriconazole Sales (K Pcs) by Type (2018-2023)
Table 17. Europe Voriconazole Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Voriconazole Sales (K Pcs) by Type (2018-2023)
Table 19. Asia-Pacific Voriconazole Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Voriconazole Sales (K Pcs) by Type (2018-2023)
Table 21. Latin America Voriconazole Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Voriconazole Sales (K Pcs) by Type (2018-2023)
Table 23. Middle East and Africa Voriconazole Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Voriconazole Sales by Company (2018-2023) & (K Pcs)
Table 25. Global Voriconazole Sales Share by Company (2018-2023)
Table 26. Global Voriconazole Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Voriconazole Revenue Share by Company (2018-2023)
Table 28. Global Market Voriconazole Price by Company (2018-2023) & (USD/Pcs)
Table 29. Global Voriconazole Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Voriconazole Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Voriconazole as of 2022)
Table 32. Date of Key Manufacturers Enter into Voriconazole Market
Table 33. Key Manufacturers Voriconazole Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Voriconazole Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Voriconazole Sales by Region (2018-2023) & (K Pcs)
Table 37. Global Voriconazole Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Voriconazole Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Voriconazole Sales Market Share in Value by Region (2018-2023)
Table 40. Global Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 41. Global Voriconazole Sales by Region (2024-2029) & (K Pcs)
Table 42. Global Voriconazole Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Voriconazole Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Voriconazole Sales Market Share in Value by Region (2024-2029)
Table 45. Global Voriconazole Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
Table 46. Global Voriconazole Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Voriconazole Sales by Application (2018-2023) & (K Pcs)
Table 48. Global Voriconazole Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Voriconazole Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Voriconazole Sales Market Share in Value by Application (2018-2023)
Table 51. Global Voriconazole Price by Application (2018-2023) & (USD/Pcs)
Table 52. Global Voriconazole Sales by Application (2024-2029) & (K Pcs)
Table 53. Global Voriconazole Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Voriconazole Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Voriconazole Sales Market Share in Value by Application (2024-2029)
Table 56. Global Voriconazole Price by Application (2024-2029) & (USD/Pcs)
Table 57. North America Voriconazole Sales by Application (2018-2023) (K Pcs)
Table 58. North America Voriconazole Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Voriconazole Sales by Application (2018-2023) (K Pcs)
Table 60. Europe Voriconazole Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Voriconazole Sales by Application (2018-2023) (K Pcs)
Table 62. Asia-Pacific Voriconazole Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Voriconazole Sales by Application (2018-2023) (K Pcs)
Table 64. Latin America Voriconazole Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Voriconazole Sales by Application (2018-2023) (K Pcs)
Table 66. Middle East and Africa Voriconazole Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Voriconazole Sales by Country (2018-2023) & (K Pcs)
Table 68. North America Voriconazole Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Voriconazole Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Voriconazole Sales Market Share in Value by Country (2018-2023)
Table 71. North America Voriconazole Sales by Country (2024-2029) & (K Pcs)
Table 72. North America Voriconazole Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Voriconazole Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Voriconazole Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Voriconazole Sales by Country (2018-2023) & (K Pcs)
Table 76. Europe Voriconazole Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Voriconazole Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Voriconazole Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Voriconazole Sales by Country (2024-2029) & (K Pcs)
Table 80. Europe Voriconazole Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Voriconazole Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Voriconazole Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Voriconazole Sales by Region (2018-2023) & (K Pcs)
Table 84. Asia-Pacific Voriconazole Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Voriconazole Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Voriconazole Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Voriconazole Sales by Region (2024-2029) & (K Pcs)
Table 88. Asia-Pacific Voriconazole Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Voriconazole Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Voriconazole Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Voriconazole Sales by Country (2018-2023) & (K Pcs)
Table 92. Latin America Voriconazole Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Voriconazole Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Voriconazole Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Voriconazole Sales by Country (2024-2029) & (K Pcs)
Table 96. Latin America Voriconazole Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Voriconazole Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Voriconazole Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Voriconazole Sales by Country (2018-2023) & (K Pcs)
Table 100. Middle East and Africa Voriconazole Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Voriconazole Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Voriconazole Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Voriconazole Sales by Country (2024-2029) & (K Pcs)
Table 104. Middle East and Africa Voriconazole Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Voriconazole Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Voriconazole Sales Market Share in Value by Country (2024-2029)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 110. Pfizer Voriconazole Product
Table 111. Pfizer Recent Development
Table 112. Teva Company Information
Table 113. Teva Introduction and Business Overview
Table 114. Teva Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 115. Teva Voriconazole Product
Table 116. Teva Recent Development
Table 117. GeneTech Pharm Company Information
Table 118. GeneTech Pharm Introduction and Business Overview
Table 119. GeneTech Pharm Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 120. GeneTech Pharm Voriconazole Product
Table 121. GeneTech Pharm Recent Development
Table 122. Novartis Company Information
Table 123. Novartis Introduction and Business Overview
Table 124. Novartis Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 125. Novartis Voriconazole Product
Table 126. Novartis Recent Development
Table 127. Mylan Company Information
Table 128. Mylan Introduction and Business Overview
Table 129. Mylan Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 130. Mylan Voriconazole Product
Table 131. Mylan Recent Development
Table 132. Squibb Company Information
Table 133. Squibb Introduction and Business Overview
Table 134. Squibb Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Squibb Voriconazole Product
Table 136. Squibb Recent Development
Table 137. Sandoz Company Information
Table 138. Sandoz Introduction and Business Overview
Table 139. Sandoz Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Sandoz Voriconazole Product
Table 141. Sandoz Recent Development
Table 142. Daiichi Sankyo Company Information
Table 143. Daiichi Sankyo Introduction and Business Overview
Table 144. Daiichi Sankyo Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 145. Daiichi Sankyo Voriconazole Product
Table 146. Daiichi Sankyo Recent Development
Table 147. GSK Company Information
Table 148. GSK Introduction and Business Overview
Table 149. GSK Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 150. GSK Voriconazole Product
Table 151. GSK Recent Development
Table 152. Cilag AG Company Information
Table 153. Cilag AG Introduction and Business Overview
Table 154. Cilag AG Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 155. Cilag AG Voriconazole Product
Table 156. Cilag AG Recent Development
Table 157. Macherey-Nagel GmbH Company Information
Table 158. Macherey-Nagel GmbH Introduction and Business Overview
Table 159. Macherey-Nagel GmbH Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 160. Macherey-Nagel GmbH Voriconazole Product
Table 161. Macherey-Nagel GmbH Recent Development
Table 162. Abbott Company Information
Table 163. Abbott Introduction and Business Overview
Table 164. Abbott Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 165. Abbott Voriconazole Product
Table 166. Abbott Recent Development
Table 167. Takeda Company Information
Table 168. Takeda Introduction and Business Overview
Table 169. Takeda Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 170. Takeda Voriconazole Product
Table 171. Takeda Recent Development
Table 172. Sichuan Beauty Sport Huakang Pharmaceutical Company Information
Table 173. Sichuan Beauty Sport Huakang Pharmaceutical Introduction and Business Overview
Table 174. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 175. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product
Table 176. Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
Table 177. Jincheng HEALTH Pharmaceutical Company Information
Table 178. Jincheng HEALTH Pharmaceutical Introduction and Business Overview
Table 179. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 180. Jincheng HEALTH Pharmaceutical Voriconazole Product
Table 181. Jincheng HEALTH Pharmaceutical Recent Development
Table 182. Ebang Pharmaceutical Company Information
Table 183. Ebang Pharmaceutical Introduction and Business Overview
Table 184. Ebang Pharmaceutical Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 185. Ebang Pharmaceutical Voriconazole Product
Table 186. Ebang Pharmaceutical Recent Development
Table 187. Aditya Pharma Company Information
Table 188. Aditya Pharma Introduction and Business Overview
Table 189. Aditya Pharma Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 190. Aditya Pharma Voriconazole Product
Table 191. Aditya Pharma Recent Development
Table 192. Taj Pharmaceuticals Company Information
Table 193. Taj Pharmaceuticals Introduction and Business Overview
Table 194. Taj Pharmaceuticals Voriconazole Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 195. Taj Pharmaceuticals Voriconazole Product
Table 196. Taj Pharmaceuticals Recent Development
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Voriconazole Market Trends
Table 200. Voriconazole Market Drivers
Table 201. Voriconazole Market Challenges
Table 202. Voriconazole Market Restraints
Table 203. Voriconazole Distributors List
Table 204. Voriconazole Downstream Customers
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Voriconazole Product Picture
Figure 2. Global Voriconazole Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Voriconazole Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Voriconazole Sales Status and Outlook (2018-2029) & (K Pcs)
Figure 5. Product Picture of Injection Voriconazole
Figure 6. Global Injection Voriconazole Sales YoY Growth (2018-2029) & (K Pcs)
Figure 7. Product Picture of Voriconazole Freeze-dried Powder
Figure 8. Global Voriconazole Freeze-dried Powder Sales YoY Growth (2018-2029) & (K Pcs)
Figure 9. Global Voriconazole Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Voriconazole Sales Market Share by Type in 2022 & 2029
Figure 11. North America Voriconazole Sales Market Share in Volume by Type in 2022
Figure 12. North America Voriconazole Sales Market Share in Value by Type in 2022
Figure 13. Europe Voriconazole Sales Market Share in Volume by Type in 2022
Figure 14. Europe Voriconazole Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Voriconazole Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Voriconazole Sales Market Share in Value by Type in 2022
Figure 17. Latin America Voriconazole Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Voriconazole Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Voriconazole Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Voriconazole Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Voriconazole Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Voriconazole Revenue in 2022
Figure 23. Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Pcs)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2029) & (K Pcs)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2029) & (K Pcs)
Figure 30. Global Voriconazole Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Voriconazole Sales Market Share by Application in 2022 & 2029
Figure 32. North America Voriconazole Sales Market Share in Volume by Application in 2022
Figure 33. North America Voriconazole Sales Market Share in Value by Application in 2022
Figure 34. Europe Voriconazole Sales Market Share in Volume by Application in 2022
Figure 35. Europe Voriconazole Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Voriconazole Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Voriconazole Sales Market Share in Value by Application in 2022
Figure 38. Latin America Voriconazole Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Voriconazole Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Voriconazole Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Voriconazole Manufacturing Cost Structure
Figure 43. Voriconazole Industrial
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs